D-1370-2020 Class II Terminated
FDA drug recall D-1370-2020 was initiated by Aurobindo Pharma USA Inc. on Jun 12, 2020 and is designated Class II. Reason for recall: Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg. The recall status is terminated (terminated Dec 21, 2022). Affected quantity: 1440 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 1, 2020
- Initiation Date
- Jun 12, 2020
- Termination Date
- Dec 21, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1440 bottles
Product description
Clozapine Tablets USP tablet, 100mg, 500-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520, Made in India, NDC 65862-846-05
Reason for recall
Presence of foreign tablet: Consumer complaint of Clozapine Tablets 50mg being present in 500 count bottles of Clozapine Tablets USP 100mg.
Distribution pattern
U.S.A. Nationwide
Code information
Lot #: CZSC20003-A, Exp 1/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1370-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026